The impact of Trump's tariffs is spreading to the U.S. stock IPO market, causing changes in the listing plans of multiple companies.

[The Trump Tariff Impact Spreads to the U.S. Stock IPO Market, Several Companies’ Listing Plans Change] According to the Wall Street Journal, the glimmer of hope for a revival of U.S. IPOs is fading. According to insiders, the ticketing market StubHub and fintech company Klarna have postponed their IPO roadshows originally scheduled to start next week. Some say that another fintech company, Chime, is also delaying its submission of public financial reports to regulators and has postponed its IPO. Insiders say that virtual physical therapy company Hinge Health is following the market and is expected to go public at the end of April. The cryptocurrency company Circle is close to the next step in its IPO process but is currently anxiously watching before deciding what to do. Additionally, there are reports that medical technology company Medline has postponed its U.S. IPO. The big dump in the stock market on Thursday and Friday has closed the door for companies waiting to go public. Over the past three years, the U.S. IPO market has experienced a tough period, but many bankers and lawyers hope that 2025 will be a year of normalcy for IPOs. In contrast, the global trade war is stirring the stock market, leaving investors and executives uneasy.